Low-Dose Azacitidine Maintenance Therapy Post-Allogeneic Stem Cell Transplantation for High-Risk Pediatric Acute Myeloid Leukemia

被引：0
|
作者：
Tamura, A. [1 ]
Ishida, T. [1 ]
Saito, A. [1 ]
Yamamoto, N. [1 ]
Yokoi, T. [2 ]
Uemura, S. [3 ]
Nino, N. [1 ]
Nakamura, S. [1 ]
Kozaki, A. [1 ]
Kishimoto, K. [1 ]
Hasegawa, D. [1 ]
Kosaka, Y. [1 ]
机构：
[1] Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo, Japan
[2] Osaka Univ Hosp, Dept Pediat, Suita, Osaka, Japan
[3] Kobe Univ Hosp, Dept Pedict, Pedictr, Kobe, Hyogo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-217
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [21] A dose and schedule finding study of maintenance therapy with low-dose 5-azacitidine (AZA) after allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk AML or MDS
    de Lima, Marcos
    Padua, L.
    Giralt, S.
    Hosini, C.
    Komanduri, K.
    Qazilbash, M.
    Shpall, E. J.
    Thall, P.
    Qureshi, S.
    McCormick, G.
    Tong, W.
    Popat, U.
    Soriano, A.
    Champlin, R.
    Garcia-Manero, G.
    BLOOD, 2007, 110 (11) : 884A - 885A
  • [22] Azacitidine maintenance after allogeneic stem cell transplantation is feasible in patients with acute myeloid leukemia and myelodysplasia
    Antar, A.
    Kharfan-Dabaja, M.
    Abou Ghaddara, H.
    Mahfouz, R.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S258 - S258
  • [23] Azacitidine Maintenance after Allogeneic Stem Cell Transplantation Is Feasible in Patients with Acute Myeloid Leukemia and Myelodysplasia
    Antar, Ahmad
    Kharfan-Dabaja, Mohamed A.
    Abou Ghaddara, Hussein
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
  • [24] Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia
    Huschart, Emily
    Miller, Holly
    Salzberg, Dana
    Campbell, Courtney
    Beebe, Kristen
    Schwalbach, Charlotte
    Magee, Kyrie
    Adams, Roberta H.
    Ngwube, Alexander
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (02) : 154 - 160
  • [25] Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Xuan, Li
    Liu, Qifa
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [26] Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Li Xuan
    Qifa Liu
    Journal of Hematology & Oncology, 14
  • [27] Phase II Trial of Venetoclax (Ven) in Combination with Azacitidine (AZA) As Maintenance Therapy for High-Risk Acute Leukemia Following Allogeneic Stem Cell Transplantation (SCT)
    Oran, Betul
    Champlin, Richard E.
    Thall, Peter F.
    McCarty, Jessica M.
    Zhang, Wen
    Marin, David
    Mehta, Rohtesh S.
    Alousi, Amin M.
    Alatrash, Gheath
    Popat, Uday R.
    Kantarjian, Hagop
    Bashir, Qaiser
    Shpall, Elizabeth J.
    Konopleva, Marina
    BLOOD, 2022, 140 : 10561 - 10562
  • [28] Hypomethylating Agents and Low-Dose Venetoclax for Relapse Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
    Vigil, Carlos Enrique
    Silverman, Margarida
    Carter, Thomas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S104 - S104
  • [29] Maintenance Therapy with Decitabine after Allogeneic Hematopoietic Stem Cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia
    Ma, Yunju
    Qu, Changju
    Dai, Haiping
    Yin, Jia
    Li, Zheng
    Chen, Jia
    Qiu, Huiying
    Sun, Aining
    Miao, Miao
    Fu, Chengcheng
    Jin, Zhengming
    Zhu, Xiaming
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2019, 134
  • [30] Acute myeloid leukemia post-allogeneic peripheral stem cell transplant with gastric chloroma
    Rehman, Jalil Ur
    Shinawi, Mohammad
    Aslam, Muhammad
    Kelta, Mouhammad
    ANNALS OF SAUDI MEDICINE, 2011, 31 (06) : 658 - 660
12345